• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Clin Pract . Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019

tetano

Editor, Senior Moderator
Int J Clin Pract


. 2021 Apr 21;e14257.
doi: 10.1111/ijcp.14257. Online ahead of print.
Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019


Yuhong Chen[SUP] 1 [/SUP], Haijun Zhi[SUP] 2 [/SUP], Kun Zhang[SUP] 1 [/SUP], Guijun Zhu[SUP] 1 [/SUP], Lixia Liu[SUP] 1 [/SUP], Xixin Yan[SUP] 3 [/SUP], Zhigang Cai[SUP] 3 [/SUP], Congcong Zhao[SUP] 1 [/SUP], Zhenjie Hu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Novel coronavirus disease 2019 (COVID-19) poses a huge threat to the global public health. This study aimed to identify predictive indicators of severe COVID-19.
Methods: We retrospectively collected clinical data on hospital admission of all patients with severe COVID-19 and a control cohort (1:1) of gender- and hospital-matched patients with mild disease from 13 designated hospitals in the Hebei province between 22 January and 15 April 2020.
Results: A total of 104 patients (52 with severe COVID-19 and 52 with mild disease) were included. Only age, fever, duration from symptom onset to confirmation, respiratory rate, percutaneous oxygen saturation (SpO[SUB]2[/SUB] ), and neutrophilic percentage were independent predictors of severe COVID-19. Age and neutrophilic percentage performed best in predicting severe COVID-19, followed by SpO[SUB]2[/SUB] . "Age + Neutrophilic percentage" (the sum of age and neutrophilic percentage) (area under the curve [AUC] 0.900, 95% confidence interval [CI] 0.825-0.950, P<0.001) and "Age and Neutrophilic percentage" (the prediction probability of age and neutrophilic percentage for severe type obtained by Logistic regression analysis) (AUC 0.899, 95% CI 0.824-0.949, P<0.001) had excellent predictive performance for severe type. The optimal cut-off for "Age + Neutrophilic percentage" was >119.1 (sensitivity, 86.5%; specificity, 84.6%; Youden index, 0.712).
Conclusion: The combination of age and neutrophil percentage could effectively predict severe COVID-19. The sum of age and neutrophil percentage was recommended for clinical application because of its excellent predictive value and practicability.

Keywords: 2019 novel coronavirus; COVID-19; SARS-CoV-2; age; neutrophilic percentage; severe type patients.
 
Back
Top Bottom